IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Mankind Pharma IPO listing price is ₹ 1424.05, issue price is ₹ 1080.00, and currently trading at ₹ 2361.70 as on July 3, 2025. Mankind Pharma IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Mankind Pharma IPO is a Book Building listing on BSE,NSE exchange. The company is based in New Delhi and caters to Pharmaceutical sector. Axis Capital , IIFL Securities , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Mankind Pharma IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th September 2022.
Mankind Pharma IPO offer price is ₹ 1080.00 and got listed at ₹ 1424.05. Read Mankind Pharma IPO details mentioned above.The IPO of Mankind Pharma Limited was listed on 9th May 2023. As of today, Mankind Pharma IPO is trading at ₹ 2361.70, compared to the previous day’s close of ₹ 2384.70. Read the report above for detailed IPO performance.
The issue price of Mankind Pharma IPO was ₹ 1080.00 per equity share.
Mankind Pharma IPO was listed at ₹1424.05 on the stock exchange on 9th May 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of July 3, 2025, the current market price of Mankind Pharma IPO is ₹ 2361.70.
The 52-week high for Mankind Pharma IPO is ₹ 3054.80, while the 52-week low is ₹ 1901.05. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Mankind Pharma IPO listed at ₹ 1424.05 against the issue price of ₹ 1080.00 per equity share, showing a listing day gain/loss of 344.05 (31.86%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Mankind Pharma IPO stock moved from its listing price of ₹ 1424.05 to the current price of ₹2361.70 per equity share, reflecting a change of 65.84% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Mankind Pharma IPO issue date of 9th May 2023 and CMP of ₹2361.70, the estimated CAGR is approximately 43.55%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 1
Issue
Price :
₹ 1080.00
Listing Price :
₹ 1424.05
Previous Day Closing
₹ 2384.70
Mankind Pharma IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Mankind Pharma Financial Review Page
Merchant Banker(s) of Mankind Pharma IPO: Axis Capital Limited , IIFL Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Mankind Pharma IPO subscription was 15.32 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Mankind Pharma IPO listed at a listing price of 1424.05 against the offer price of 1080.00.
The current market price of Mankind Pharma is 2361.70.
Why Us?
